References
- Sayiner M, Golabi P, Younossi ZM. Disease burden of hepatocellular carcinoma: a global perspective. Dig Dis Sci. 2019;64:910–917. doi:https://doi.org/10.1007/s10620-019-05537-2.
- Ding Y, Wu Z, Wei Y, Shu L, Peng Y. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine. J Cancer Res Clin Oncol. 2017;143:821–834. doi:https://doi.org/10.1007/s00432-017-2364-z
- Jüngst C, Cheng B, Gehrke R, Schmitz V, Nischalke HD, Ramakers J, Schramel P, Schirmacher P, Sauerbruch T, Caselmann WH. Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology. 2004;39:1663–1672. doi:https://doi.org/10.1002/hep.20241
- Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature. 2008;454:455–462. doi:https://doi.org/10.1038/nature07203
- Roller C, Maddalo D. The molecular chaperone GRP78/BiP in the development of chemoresistance: mechanism and possible treatment. Front Pharmacol. 2013;4:10. doi:https://doi.org/10.3389/fphar.2013.00010
- Wang C, Jiang K, Gao D, Kang X, Sun C, Zhang Q, Li Y, Sun L, Zhang S, Guo K, et al. Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78 Velasco G, editor. PLoS One. 2013;8:e55981. doi:https://doi.org/10.1371/journal.pone.0055981
- Bailly C, Waring MJ. Pharmacological effectors of GRP78 chaperone in cancers. Biochem Pharmacol. 2019;163:269–278. doi:https://doi.org/10.1016/j.bcp.2019.02.038
- Saiful Yazan L, Hafiza WN. Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy. OncoTargets Therapy. 2014;7: 1375–1387. doi:https://doi.org/10.2147/OTT.S62928
- Folayan A, Akani E, Adebayo OA, Akanni OO, Owumi SE, Tijani AS, Adaramoye OA. Ameliorative effects of hexane extract of Garcinia kola seeds Heckel (Clusiaceae) in cisplatin-induced hepatorenal toxicity in mice. Drug Chem Toxicol. 2020. doi:https://doi.org/10.1080/01480545.2020.1808671.
- Dasari S, Bernard Tchounwou P. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–378. doi:https://doi.org/10.1016/j.ejphar.2014.07.025
- Su R, Li Z, Li H, Song H, Bao C, Wei J, Cheng L. Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer. 2010;10(1):20. doi:https://doi.org/10.1186/1471-2407-10-20
- Geng W, Lo C-M, Ng KTP, Ling C-C, Qi X, Li C-X, Zhai Y, Liu X-B, Ma Y-Y, Man K. Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway. Oncotarget. 2015;6:28042–28056. doi:https://doi.org/10.18632/oncotarget.4832
- El-Far A. Thymoquinone anticancer discovery: possible mechanisms. Curr Drug Discov Technol. 2015;12:80–89. doi:https://doi.org/10.2174/1570163812666150716111821.
- Helmy SA, El-Mesery M, El-Karef A, Eissa LA, El Gayar AM. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model. Life Sci. 2019;233:116673. doi:https://doi.org/10.1016/j.lfs.2019.116673
- Zhang M, Du H, Huang Z, Zhang P, Yue Y, Wang W, Liu W, Zeng J, Ma J, Chen G, et al. Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway. Chem Biol Interact. 2018;292:65–75. doi:https://doi.org/10.1016/j.cbi.2018.06.013
- Jafri SH, Glass J, Shi R, Zhang S, Prince M, Kleiner-Hancock H. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo. J Exp Clin Cancer Res. 2010;29(1):87. doi:https://doi.org/10.1186/1756-9966-29-87
- Noorwali A, Aloafi O, Al-Attas S, Zahran F, Al-Abd AM. Thymoquinone synergizes the anticancer properties of cisplatin against head and neck squamous cell carcinoma and protects normal oral epithelial cells. Cancer Chem. 2017;77(13):2176–2176. doi:https://doi.org/10.1158/1538-7445.AM2017-2176
- Shoieb A, Elgayyar M, Dudrick P, Bell J, Tithof P. In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol. 2003;22(1):107–113. doi:https://doi.org/10.3892/ijo.22.1.107
- Ulu R, Dogukan A, Tuzcu M, Gencoglu H, Ulas M, İlhan N, Muqbil I, Mohammad RM, Kucuk O, Sahin K. Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury. Food Chem Toxicol. 2012;50:1675–1679. doi:https://doi.org/10.1016/j.fct.2012.02.082
- Saleem S, Kazmi I, Ahmad A, Abuzinadah MF, Samkari A, Alkrathy HM, Khan R. Thiamin regresses the anticancer efficacy of methotrexate in the amelioration of diethyl nitrosamine-induced hepatocellular carcinoma in Wistar strain rats. Nutr Cancer. 2020;72(1):170–181. doi:https://doi.org/10.1080/01635581.2019.1614199
- Abdel-Hamid NM, Nazmy MH, Nazmy WH. Vitamin C and diallyl sulfide as chemosensitizers to cisplatin in treating hepatocellular carcinoma. J Solid Tumors. 2011;1:90–103. doi:https://doi.org/10.5430/jst.v1n3p90
- Hassan H, Serag H, Abdel-Hamid N, Amr M. Synergistic curative effect of chicory extract and cisplatin against thioacetamide-induced hepatocellular carcinoma. Hepatoma Res. 2015;1:147–154. doi:https://doi.org/10.4103/2394-5079.167376
- Neideen T, Brasel K. Understanding statistical tests. J Surg Educ. 2007;64:93–96. doi:https://doi.org/10.1016/j.jsurg.2007.02.001
- Mansour DF, Abdallah HMI, Ibrahim BMM, Hegazy RR, Esmail RSE, Abdel-Salam LO. The carcinogenic agent diethylnitrosamine induces early oxidative stress, inflammation and proliferation in rat liver, stomach and colon: protective effect of ginger extract. Asian Pac J Cancer Prev. 2019;20:2551–2561. doi:https://doi.org/10.31557/APJCP.2019.20.8.2551
- Marra M, Sordelli IM, Lombardi A, Lamberti M, Tarantino L, Giudice A, Stiuso P, Abbruzzese A, Sperlongano R, Accardo M, et al. Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med. 2011;9(1):171. doi:https://doi.org/10.1186/1479-5876-9-171
- Fabregat I. Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol. 2009;15:513–520. doi:https://doi.org/10.3748/wjg.15.513
- Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal. 2007;9:2277–2294. doi:https://doi.org/10.1089/ars.2007.1782
- Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004;11:381–389. doi:https://doi.org/10.1038/sj.cdd.4401373
- Lei Y, Wang S, Ren B, Wang J, Chen J, Lu J, Zhan S, Fu Y, Huang L, Tan J. CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy Pizzo S V, editor. PLoS One. 2017;12:e0183680. doi:https://doi.org/10.1371/journal.pone.0183680
- Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31:1869–1883. doi:https://doi.org/10.1038/onc.2011.384
- Mandic A, Hansson J, Linder S, Shoshan MC. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem. 2003;278:9100–9106. doi:https://doi.org/10.1074/jbc.M210284200
- Gu Y-J, Li H-D, Zhao L, Zhao S, He W-B, Rui L, Su C, Zheng H-C, Su R-J. GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS Axis in hepatocellular carcinoma. Oncotarget. 2015;6:33658–33674. doi:https://doi.org/10.18632/oncotarget.5603
- Lin Y, Wang Z, Liu L, Chen L. Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells. Lung Cancer. 2011;71:291–297. doi:https://doi.org/10.1016/j.lungcan.2010.06.004
- Xu D, Ma Y, Zhao B, Li S, Zhang Y, Pan S, Wu Y, Wang J, Wang D, Pan H, et al. Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo. Oncol Rep. 2014;31:2063–2070. doi:https://doi.org/10.3892/or.2014.3059
- Wilson AJ, Saskowski J, Barham W, Yull F, Khabele D. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer. J Ovarian Res. 2015;8(1):46. doi:https://doi.org/10.1186/s13048-015-0177-8